HEPATIC AMYLOIDOSIS – CASE REPORT AND LITERATURE REVIEW
Abstract
BACKGROUND Amyloidosis is a disorder of protein metabolism that leads to extracellular deposition ofinsoluble proteinaceous material. Clinically important are amyloidosis AL and AA. Primaryor AL form is associated with immunocyte dyscrasia, multiple myeloma, macroglobulinemiaor monoclonal gammopathy, the precursor protein are immunoglobulin lightchains. Amyloidosis AA or reactive amyloidosis is associated with chronic inflammatorydisease.Patients and The authors are presenting a 52-year old man who was transferred to their department formethods diagnostic proceedings of anaemia and liver disease from the department of orthopaedics,where he was treated for compression fractures of the spine. Unfortunately, during the firsthospitalisation the patient refused liver biopsy. The patient died due to spleenic ruptureand exsanguination into abdominal cavity. At autopsy, amyloidosis was found withamyloid deposits in the liver and other organs. In the article, different forms of this diseasewith grim prognosis are described. CONCLUSIONS The authors presented a patient with primary amyloidosis which led to fatal complication.According to the literature, patients with this form of amyloidosis have median survival of1–2 years from establishing the diagnosisDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
